Shares of 3D printing company 3D Systems (NYSE:DDD) fell 25.8% in the afternoon session after the company reported disappointing first quarter 2025 results: its revenue, EPS, and EBITDA missed Wall Street's estimates significantly. Revenue declined, largely tied to a drop in materials sales in the dental market, where customers cut orders to manage inventory. Looking ahead, management pulled full-year guidance, citing uncertainty in customer budgets and global tariff risks. Overall, this was a weaker quarter.
3D printing company 3D Systems (NYSE:DDD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 8.1% year on year to $94.54 million. Its non-GAAP loss of $0.21 per share was 44.8% below analysts’ consensus estimates.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment.
Small-cap stocks in the Russell 2000 can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Shares of 3D printing company 3D Systems (NYSE:DDD) fell 19.9% in the afternoon session after the company reported weak fourth-quarter 2024 results, which missed across the key metrics we track, including sales, operating income, and earnings. The major highlight for the quarter was the steep 21% drop in Healthcare revenue, largely tied to a change in accounting in its Regenerative Medicine program, which masked positive momentum in other areas.
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we will witness groundbreaking changes that redefine how care is delivered, diseases are treated, and wellness is maintained. Below, we explore ten
3D printing company 3D Systems (NYSE:DDD) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $111 million. The company’s full-year revenue guidance of $427.5 million at the midpoint came in 7.4% below analysts’ estimates. Its non-GAAP loss of $0.19 per share was 72.7% below analysts’ consensus estimates.
